Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Fisher & Paykel Healthcare Corporation Limited ( (NZ:FPH) ) just unveiled an update.
Pinnacle Investment Management Group Limited and its related entities have disclosed that they have begun a substantial holding in Fisher & Paykel Healthcare, acquiring 29,449,552 ordinary shares. This stake represents 5.0145% of Fisher & Paykel Healthcare’s 587,289,009 quoted voting shares, held across multiple custodians including Citicorp Nominees, State Street and JP Morgan.
The disclosure, made under New Zealand’s Financial Markets Conduct Act, reflects Pinnacle’s relevant interests obtained through affiliated investment managers and fund structures. The move signals growing institutional interest in Fisher & Paykel Healthcare, potentially enhancing the company’s shareholder base depth and liquidity, and may influence governance dynamics given the concentrated voting power.
The most recent analyst rating on (NZ:FPH) stock is a Hold with a N$39.50 price target. To see the full list of analyst forecasts on Fisher & Paykel Healthcare Corporation Limited stock, see the NZ:FPH Stock Forecast page.
More about Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare Corporation Limited is a New Zealand-based medical technology company that designs and manufactures respiratory care and other healthcare products. Its primary focus is on hospital and home care solutions, serving global markets through listed ordinary shares on the NZX and ASX.
YTD Price Performance: -12.98%
Average Trading Volume: 505,783
Technical Sentiment Signal: Hold
Current Market Cap: N$19.29B
See more insights into FPH stock on TipRanks’ Stock Analysis page.

